The World Health Organization recommends monitoring alcohol-based handrub (ABHR) consumption and direct observation of hand hygiene practices to ensure compliance. In Japan monitoring of ABHR consumption is widely performed. However, direct observation is not common, particularly in small facilities and non-acute-care facilities. Hence, the current study aimed to evaluate the longitudinal effects of direct observation of hand hygiene practices and monitoring of ABHR consumption with provision of feedback to healthcare personnel on ABHR consumption and hand hygiene compliance. We conducted a 4-year prospective intervention study. Monitoring of ABHR consumption and direct observation of hand hygiene practices with monthly feedback to healthcare personnel was implemented in 17 facilities. These consisted of 11 acute-care facilities of varying sizes and six non-acute-care facilities. A generalized linear mixed model analysis was performed to assess factors associated with ABHR consumption. All facilities implemented ABHR consumption monitoring within one month of starting the study. However, the mean time required to implement direct observation of hand hygiene practices was 24.7 (±19.1) months. The ABHR consumption increased significantly (P<0.0001) in all medical facilities after implementing the direct observation. Multivariable regression analysis showed the hospital ward type, duration of ABHR consumption monitoring, and duration of direct observation of hand hygiene practices were independently associated with ABHR consumption. Direct observation of hand hygiene practices with feedback should be implemented more widely in combination with ABHR consumption monitoring to help increase hand hygiene compliance.
Objective: Cataracts are the leading cause of poor vision in Japanese adults. As Japan’s population is rapidly ageing, the demand for cataract surgery will continue to increase. Despite this, quantitative research evaluating both supply and demand of cataract surgery is lacking. The objective of this study was to forecast future cataract surgery demand and the supply of ophthalmologists in Japan by region and evaluate the cataract surgery demand-supply balance considering regional differences in demographics and medical resources. Methods and analysis: Based on the Ministry of Health, Labour and Welfare’s ‘NDB Open Data’, age-specific and sex-specific cataract surgery rates were calculated from the number of billed procedures. These rates were applied to the Ministry of Internal Affairs and Communications’ ‘Population Estimates’ and National Institute of Population and Social Security Research’s ‘Future Population Projections’ to estimate demand for 2030, 2040 and 2050. Future supply of ophthalmologists was estimated using linear regression based on data from the ‘Survey of Physicians, Dentists, and Pharmacists’. The demand-supply ratio (demand divided by supply) was calculated for each prefecture. The demand-supply ratio multiplier for each year was calculated using 2022 as the base year. Results: The estimated number of cataract surgeries was 1 929 848 in 2030, 2 373 260 in 2040 and 2 863 733 in 2050, with a significant increase projected for individuals in their 70s and aged 80+. Although most prefectures were expected to see a gradual increase in ophthalmologist numbers, a decrease was projected for some regional areas. Consequently, the demand-supply ratio was projected to increase nationwide, with a larger increase in regional areas, suggesting a widening disparity between regional and metropolitan areas. Conclusion: Demand for cataract surgery would continue to rise, potentially increasing demand-supply imbalances, particularly in regions with ageing populations. Re-examination of the regional allocation of medical resources is necessary to correct disparities in access to treatment. These projections are subject to limitations related to the use of publicly available data and assumptions based on past trends, which may not fully reflect regional practice variation or future changes in surgical capacity.
Intracordal trafermin injection (ITI) can improve vocal function in patients with unilateral vocal fold paralysis (UVFP) by promoting tissue regeneration and enhancing glottal gap. However, evidence on long-term and longitudinal outcomes remains limited. This study aimed to evaluate long-term and longitudinal outcomes of ITI in patients with UVFP. This retrospective study was approved by the Ethics Committee (Approval No.22-S-11) and conducted at the Tokyo Voice Center between 2014 and 2025 using medical records. The final analysis included 221 cases. We extracted data on sex, age, dose, causative disease of UVFP, voice data (maximum phonation time [MPT], pitch range [PR], mean flow rate [MFR], and voice handicap index [VHI]), and the number of days from ITI to voice data measurement. This study did not estimate individual longitudinal changes; instead, it integrated days and improvements in all patients after ITI. Regarding the long-term outcomes, no significant correlation was observed in the relationship between the number of days after ITI and voice improvement for MPT, PR, MFR, and VHI. All voice data improved over all periods. Regarding longitudinal outcomes, a generalized linear mixed-effects model analysis revealed no significant association between the number of days after ITI and VHI. Although significant differences were observed for MPT and PR, the estimated effect sizes were minimal and did not indicate clinically meaningful changes. Voice improvement was achieved immediately after ITI and was maintained over the long term. However, longitudinal outcomes did not fully align with our clinical experience.